|
|
Williams lashes cancer inquiry for 'inquisitorial methods'
|
Biopharmaceutical company Aldagen plans IPO
|
Increase the Value of Your Intellectual Property
|
Therapeutic DNA Vaccine Company Inovio Biomedical Reports First Quarter 2008 Financial Results
|
Biopharmaceutical company Aldagen registers for initial public offering
|
Therapeutic DNA Vaccine Company Inovio Biomedical Reports First Quarter 2008 Financial Results
|
Hairdressers at increased risk of cancer
|
Firefighters show higher risk of cancer
|
Williams unrepentant about comments on breast-cancer inquiry
|
Par Pharma 1Q earnings fall, but shares rise on adj. profit
|
BioSante Pharmaceuticals Reports First Quarter 2008 Financial Results
|
Market Regulation Services Inc.: Resume, DEVSTUDIOS INTERNATIONAL INC., MISTRAL PHARMA INC., PARKLAND ENERGY S
|
Prostate cancer deaths fall after screening program
|
Elixir Pharmaceuticals withdraws registration for initial public offering
|
Par Pharmaceutical 1Q earnings fall 94 percent, but shares up on adjusted profit
|
Keryx Biopharmaceuticals, Inc. Announces First Quarter 2008 Financial Results
|
West Pharmaceutical Services declares regular quarterly dividend of 14 cents, payable Aug. 6
|
Williams defends statement that N.L. breast-cancer inquiry a 'prosecution'
|
Market Regulation Services - Trade Resumption - Mistral Pharma Inc. - MIP
|
Market Regulation Services Inc.: Resume, DEVSTUDIOS INTERNATIONAL INC., MISTRAL PHARMA INC., PARKLAND ENERGY S
|
